ramoplanin A2: macrocyclic depsipeptide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16129628 |
| CHEBI ID | 29670 |
| MeSH ID | M0373402 |
| Synonym |
|---|
| 81988-88-7 |
| ramoplanin a2 |
| C12008 , |
| ramoplanin a2 (main component) |
| ramoplanin a 1 (peptide moiety), 1-(n(sup 2)-(7-methyl-1-oxo-2,4-octadienyl)-l-asparagine)-11-(l-2-(4-((2-o-alpha-d-mannopyranosyl-alpha-d-mannopyranosyl)oxy)phenyl)glycine)-,(z,z)- |
| unii-i9bj0br28x |
| i9bj0br28x , |
| ramoplanin a 1, 1-(n2-((2z,4e)-7-methyl-1-oxo-2,4-octadien-1-yl)-l-asparagine)- |
| ramoplanin a2 [mi] |
| antibiotic a-16686a2 |
| CHEBI:29670 |
| Class | Description |
|---|---|
| polyol | A compound that contains two or more hydroxy groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||